dEEGtal

dEEGtal.ai specializes in revolutionizing EEG analysis through advanced automation, focusing on precise detection of brain activity patterns, slowing characterization, and source localization. Designed primarily for clinicians, the platform enhances diagnostic accuracy and neural insights while significantly reducing the time to diagnosis. This allows healthcare providers to initiate treatment faster, thereby improving patient care. Founded at the University Hospital of Geneva, dEEGtal Insights emerged from the need to overcome traditional EEG analysis limitations in speed and sensitivity. The company leverages AI solutions to elevate EEG interpretation and expedite epilepsy diagnosis, positioning itself at the intersection of neuroscience and artificial intelligence. The business model revolves around providing cutting-edge technology to healthcare institutions, generating revenue through the sale and licensing of its AI-driven EEG analysis tools. dEEGtal.ai serves the healthcare market, particularly focusing on clinicians and medical institutions dealing with neurological disorders. The company fosters a collaborative work environment, prioritizing ideas and solutions over hierarchy, and is committed to making a tangible difference in patient care. Keywords: EEG, automation, brain activity, epilepsy, diagnosis, AI, healthcare, clinicians, neuroscience, patient care.